1. Home
  2. PLD vs SYK Comparison

PLD vs SYK Comparison

Compare PLD & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prologis Inc.

PLD

Prologis Inc.

HOLD

Current Price

$141.98

Market Cap

130.8B

Sector

Real Estate

ML Signal

HOLD

Logo Stryker Corporation

SYK

Stryker Corporation

HOLD

Current Price

$301.70

Market Cap

109.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLD
SYK
Founded
1983
1941
Country
United States
United States
Employees
2802
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.8B
109.3B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
PLD
SYK
Price
$141.98
$301.70
Analyst Decision
Buy
Buy
Analyst Count
18
14
Target Price
$140.78
$415.57
AVG Volume (30 Days)
2.7M
2.2M
Earning Date
04-16-2026
04-30-2026
Dividend Yield
3.08%
1.12%
EPS Growth
N/A
8.25
EPS
N/A
1.93
Revenue
N/A
$25,116,000,000.00
Revenue This Year
$1.15
$9.80
Revenue Next Year
$6.12
$8.44
P/E Ratio
$39.25
$156.75
Revenue Growth
N/A
11.16
52 Week Low
$103.02
$281.00
52 Week High
$145.44
$404.87

Technical Indicators

Market Signals
Indicator
PLD
SYK
Relative Strength Index (RSI) 54.16 41.66
Support Level $126.73 N/A
Resistance Level $144.70 $375.26
Average True Range (ATR) 2.54 8.93
MACD -0.06 -0.85
Stochastic Oscillator 55.72 39.84

Price Performance

Historical Comparison
PLD
SYK

About PLD Prologis Inc.

Prologis was formed by the 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party assets under management. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.

About SYK Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Share on Social Networks: